Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Medicare Offers Lessons For Possible 'Public Plan'
As President Barack Obama and some Democratic lawmakers push for a government-run public plan, Medicare is being scrutinized.
generic viagra online
New Mexico Department Of Health Announces Second Hantavirus Case In NM This Year
The New Mexico Department of Health announced today that a 65-year-old man from San Miguel County is hospitalized in critical condition at University of New Mexico Hospital in Albuquerque with the state"s second case of Hantavirus Pulmonary Syndrome this year. The Department of Health confirmed the case of Hantavirus on Wednesday and is conducting an environmental investigation to look for places where the man may have been exposed to the virus.
News of the day
Solomon Islands Could See Increase In HIV Cases, World Health Organization Says
A recent estimate from the World Health Organization says that the number of HIV cases in the Solomon Islands could reach at least 350 by 2010, the Solomon Star News reports. The Star News reports that 12 new HIV cases were confirmed in 2008, although the actual number of new cases could be higher because of unreported cases. Of the 12 cases reported in 2008, eight were among women and four were among men, according to a health report.In addition, sexually transmitted infections, particularly syphilis and chlamydia, are prevalent among pregnant women in the country and overall condom use is low, indicating that people could be at a high risk for HIV, according to the report. The most at-risk populations include mobile workers, commercial sex workers, students and men who have sex with men. Twelve facilities in the country currently offer HIV tests, and a relatively low number of tests are conducted, according to the Star News. The Ministry of Health has partnered with various groups and agencies to address HIV/AIDS in the country, the Star News reports (Carter, Solomon Star News, 5/26).
Endocrinology

Protalix Holds Pre-NDA Meeting With FDA For PrGCD For The Treatment Of Gaucher Disease

Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced that the Company held a pre-NDA meeting with the U.S. Food and Drug Administration (FDA). The purpose of the meeting was to discuss the a proposed new drug application (NDA) submission for prGCD, a new proprietary plant-cell expressed recombinant form of glucocerebrosidase, for the treatment of Gaucher disease and to confirm the clinical, nonclinical and chemistry requirements for the proposed NDA filing. prGCD is currently the subject of a pivotal Phase III clinical trial being conducted under the FDA"s Special Protocol Assessment (SPA) for the treatment of Gaucher disease. Gaucher disease is a rare and serious lysosomal storage disorder in humans with severe and debilitating symptoms. "This meeting gives us confidence that we will be able to submit the NDA as planned and brings us one step closer to our goal of making prGCD commercially available to Gaucher disease patients through their treating physicians," said Dr. David Aviezer, President and Chief Executive Officer. "We look forward to announcing the results of our ongoing pivotal Phase III clinical trial for prGCD in the fourth quarter of 2009 and anticipate submitting the NDA before the end of the year." Protalix BioTherapeutics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009